Saffron Recipe for Depression and Cancer

A Taste of Good Cheer: Saffron for the treatment of cancer related depression

Jacob Schor ND

There is little about having cancer that warms the heart or that triggers glee. On a list of stressful or depressing life experiences, cancer is near the top. Thus we often find cancer patients are prescribed anti-depressant medications. In certain cancers these medications may have drawbacks.

For example it has long been a common practice to prescribe SSRI antidepressants to women taking tamoxifen as this both cheers them up and seems to reduce the drug’s side effects. There is now concern that tamoxifen’s side effects decrease because the anti-depressants by interfering with the liver’s production of a particular enzyme (cyp2d6) render tamoxifen ineffective.

These same antidepressants may reduce bone growth. Though not proven, slowing bone growth, aside from contributing to osteoporosis, may have another problem as it is generally believed that this could favor growth of cancer metastases in the bone. We would prefer bones to be growing fast and staying strong.

More Than 8 Million Americans Sleepwalk, Surprising Scientists

By Stephanie Pappas, LiveScience Senior Writer | LiveScience.com

Adult sleepwalkers are more common than previously realized, with upward of 8 million American adults prone to nighttime ambulation, a new study finds.

In fact, about 3.6 percent of U.S. adults have walked in their sleep at least once in the previous year, researchers report Monday (May 14) in the journal Neurology. One percent experienced at least two episodes of sleepwalking per month.

Almost 1 in 3 in U.S. have sleepwalked: study

By Andrew M. Seaman | Reuters

NEW YORK (Reuters Health) - Although only a handful of people in the United States sleepwalk every year, a new study suggests close to one-third may do it at some point in their lives.

The study, published Monday in the journal Neurology, also suggests that other sleep disorders, severe depression and obsessive-compulsive disorder (OCD) -- among other things -- are linked to an increased chance of sleepwalking.

Past research on sleepwalking was mostly based on studies conducted in a lab, according to the study's lead author, who told Reuters Health he wanted to know what was actually happening in people's homes.

"We did not know what was the prevalence of sleepwalking -- as a disorder -- in the general population and that was a big problem," said Dr. Maurice Ohayon, director of the Stanford Sleep Epidemiology Research Center in California.

To find out how many people were sleepwalking -- also known as nocturnal wandering -- at home, Ohayon and his fellow researchers from around the U.S. called about 16,000 adults in 15 states.